title: IL-2 receptors, NK and LAK cytotoxicity of lymphocytes in breast carcinoma during prolonged thymopentin therapy.
authors: General Pathology Institute, University of Catania.
authors: C
authors: C
authors: Mazzarino
authors: A
authors: A
authors: Nicosia
authors: V
authors: V
authors: Monte
authors: S
authors: S
authors: Petralia
authors: C
authors: C
authors: Garraffo
authors: A
authors: A
authors: Girlando
authors: S
authors: S
authors: Santoro
authors: G
authors: G
authors: Malaponte
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D008134:Long-Term Care; D015375:Receptors, Interleukin-2 / Q000097:blood*; D016305:Thymopentin / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D015375:Receptors, Interleukin-2; D016305:Thymopentin